Humacyte Inc (HUMA) returns
Humacyte returns over 5 years
$1,000 invested in Humacyte five years ago was worth $45.19 at the close on October 30, 2026, with dividends reinvested: an average return of -46.2% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -20.6% | — | $794.28 | -0.9% |
| 3 months | -38.8% | — | $612.27 | +2.1% |
| Year to date | -57.2% | — | $428.11 | +11.7% |
| 1 year | -74.6% | — | $253.83 | +12.4% |
| 3 years | -79.8% | -41.4% | $201.57 | +88.5% |
| 5 years | -95.5% | -46.2% | $45.19 | +76.0% |
Humacyte return by calendar year
| Year | HUMA | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -57.2% | +11.7% | -68.9% |
| 2025 | -81.0% | +17.7% | -98.7% |
| 2024 | +77.8% | +24.9% | +52.9% |
| 2023 | +34.6% | +26.2% | +8.4% |
| 2022 | -70.9% | -18.2% | -52.7% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: HUMA financials
No forecast, no recommendation. This page describes Humacyte Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.